Implant Surgery: Osseointegration, Placement, and Complications
Osseointegration · Treatment Planning · Surgical Protocol · Bone Augmentation · Peri-implant Disease
TL;DR
Dental implant surgery involves the placement of a titanium fixture into the alveolar bone to replace a missing tooth root, upon which a prosthetic crown, bridge, or denture is subsequently attached. The biological foundation is osseointegration — the direct, load-bearing structural and functional bond between living bone and the implant surface, without interposed fibrous tissue. Modern implant dentistry offers highly predictable outcomes (≥95% 10-year survival for single implants in ideal sites), but requires rigorous treatment planning, surgical precision, and long-term maintenance.
- Osseointegration was discovered by Per-Ingvar Brånemark in 1952 and defined by Zarb in 1991 — it is the biological basis of all modern implant dentistry: Brånemark accidentally discovered that titanium had bonded directly to rabbit femoral bone during a vascular flow study. He subsequently developed the concept of osseointegration: “a direct structural and functional connection between ordered, living bone and the surface of a load-carrying implant” (Brånemark, 1985). Zarb (1991) refined this to a clinical operational definition: “a process whereby clinically asymptomatic rigid fixation of alloplastic material is achieved and maintained in bone during functional loading.” The key biological events in osseointegration: (a) primary stability — the mechanical engagement of the implant threads with bone at placement (measured by insertion torque and resonance frequency analysis [RFA/ISQ values]); (b) initial wound healing — blood clot formation around the implant surface, followed by osteogenic cell migration; (c) woven bone deposition — osteoblasts deposit new bone on the implant surface (beginning at ~2 weeks); (d) bone remodelling and maturation — woven bone is replaced by lamellar bone with organised Haversian systems in direct contact with the implant surface; (e) secondary stability — the biological stability achieved through bone-implant contact (BIC) replacing the initial mechanical stability. Modern implant surfaces are designed to accelerate and maximise osseointegration: roughened (sandblasted and acid-etched [SLA] surfaces have higher BIC% than smooth surfaces), hydrophilic (modSLA — stored in saline — accelerates protein adsorption and osteoblast attachment), and coated (hydroxyapatite coating promotes osteoblast attachment but may delaminate over time — less used now).
- Implant treatment planning requires evaluation of bone quantity, bone quality, anatomical risk structures, occlusal loading, and systemic factors: Bone quantity is assessed clinically (palpation, probe) and radiographically: periapical radiographs for vertical bone assessment; CBCT for three-dimensional bone volume, width, height, and relationship to anatomical structures (inferior alveolar canal, mental foramen, maxillary sinus floor, nasal floor). Minimum bone requirements for standard implant placement: ≥1mm of bone beyond the implant tip and beyond the implant diameter on all surfaces (buccal, lingual, mesial, distal). Bone quality: Lekholm and Zarb (1985) classification — Type I (dense cortical bone, poor vascularity, poor healing — anterior mandible); Type II (thick cortical + coarse trabecular — favourable); Type III (thin cortical + fine trabecular — common in maxilla); Type IV (very thin cortical + fine trabecular — poor — posterior maxilla; highest implant failure rate). Anatomical risk structures: inferior alveolar nerve (maintain ≥2mm clearance from implant apex); mental foramen (maintain ≥2mm from mesial/distal); maxillary sinus floor (maintain ≥1–2mm from sinus floor or perform sinus augmentation); nasal floor (uncommon limiting factor — anterior maxilla). Occlusal considerations: implants should be loaded axially wherever possible (lateral cantilever forces increase stress on the bone-implant interface); patients with bruxism require night guards and potentially modified implant prosthetic design; implant prosthetics should be planned before surgery (prosthetically-driven implant placement — the position of the implant crown determines the ideal implant position, not the available bone).
- Implant surgical timing relative to extraction is classified as immediate (Type 1), early (Types 2/3), or delayed (Type 4) — each with specific indications and biological rationale: The ITI (International Team for Implantology) consensus classification: Type 1 (Immediate placement) — implant placed into the fresh extraction socket at the same appointment; requires intact socket walls (particularly the buccal plate), no acute infection, primary closure achievable or flapless technique; reduces total treatment time; requires gap grafting between the implant and socket walls; higher aesthetic risk in the anterior maxilla due to buccal plate resorption; survival rates comparable to delayed placement in experienced hands. Type 2 (Early placement with soft tissue healing) — 4–8 weeks post-extraction; soft tissue has healed but no significant bone has formed; allows primary wound closure and facilitates hard tissue augmentation at implant placement; most common timing for augmentation cases. Type 3 (Early placement with partial bone healing) — 12–16 weeks post-extraction; partial socket bone fill has occurred; reduced augmentation needed; increased treatment time. Type 4 (Delayed/Late placement) — >6 months post-extraction; complete socket healing; most predictable bone volume (though ridge resorption has occurred); used when initial site has infection, needs ridge augmentation first, or patient requires a healing period. Socket preservation (ARP) is recommended at extraction when delayed or early implant timing is planned — particularly in the anterior aesthetic zone.
- The sinus lift (maxillary sinus floor augmentation) is the most commonly performed bone augmentation procedure in implant dentistry and is essential knowledge for board examinations: The posterior maxilla frequently has insufficient bone height for implant placement due to: (a) alveolar bone resorption following tooth loss; (b) pneumatisation of the maxillary sinus (the sinus floor descends and expands following posterior tooth loss — particularly after molar extraction). When the available bone height between the alveolar crest and the sinus floor is insufficient for standard implant placement (<10mm — some use <8mm as threshold), a sinus augmentation is required. Two surgical approaches: (1) Lateral window (Caldwell-Luc modification) — a rectangular bony window is cut in the lateral wall of the sinus; the Schneiderian membrane is elevated off the sinus floor and walls; the space is filled with bone graft material; the window is covered with a collagen membrane; implants are placed simultaneously (if ≥4–5mm residual bone available) or after a 6–9 month healing period. The Schneiderian membrane perforation is the most common intraoperative complication — if <5mm, repair with collagen membrane and continue; if >5mm, terminate and reschedule. (2) Transcrestal/Osteotome technique (Summers’ technique) — used when ≥5–6mm of residual bone is available; the osteotome is used to “tent” the sinus floor upward through the implant osteotomy without a lateral window; the graft is pushed up through the osteotomy to elevate the membrane; implant placed simultaneously. Less invasive but limited gain (~3–4mm vs. 5–15mm for lateral window). Complications of sinus lift: Schneiderian membrane perforation (most common, 10–35%); haemorrhage (posterior superior alveolar artery runs in the lateral sinus wall — seen as a red vascular channel on CBCT — must be identified and avoided); infection/sinusitis; graft failure; implant failure if inadequate healing time given.
- Peri-implant disease — peri-implant mucositis and peri-implantitis — is the leading cause of late implant failure and parallels periodontal disease in aetiology and management: Peri-implant mucositis is a reversible inflammatory condition of the soft tissue surrounding an implant, without bone loss beyond initial remodelling. It is directly analogous to gingivitis. Clinical features: bleeding on probing (BOP), erythema, oedema, and suppuration in the peri-implant sulcus; no radiographic bone loss beyond the first 1–2mm of initial crestal bone remodelling. Prevalence: ~43–50% of implant patients. Peri-implantitis is an inflammatory condition of the tissues surrounding an osseointegrated implant, characterised by both peri-implant mucosal inflammation and progressive loss of supporting bone beyond initial remodelling. It is analogous to periodontitis. Clinical features: BOP and/or suppuration; probing depths ≥6mm; radiographic bone loss ≥2–3mm (beyond initial 1–2mm crestal remodelling). Prevalence: ~20–22% of implants; ~~32% of patients at 5–10 years. Risk factors shared with periodontitis: poor oral hygiene (most important modifiable factor), smoking (impairs immune response and vascularity), history of periodontitis (strongest systemic risk factor — patients with a history of periodontitis are 3–4× more likely to develop peri-implantitis), uncontrolled diabetes, excess cement from cement-retained crowns (retained cement sub-gingivally is a leading cause of peri-implant disease). Management of peri-implantitis: non-surgical (scaling, surface decontamination — difficult due to implant surface roughness — adjunctive local antibiotics/CHX); surgical (resective: bone recontouring + implantoplasty to smooth the rough implant threads above bone; regenerative: GBR with graft and membrane around the implant to reconstruct lost bone; explantation if extensive bone loss or persistent infection).
Key Facts
What Is Implant Surgery?
Dental implant surgery involves the surgical placement of a biocompatible fixture — almost universally commercially pure titanium (cpTi) or titanium alloy (Ti-6Al-4V) — into the alveolar bone to serve as an artificial tooth root. The implant then undergoes osseointegration — direct bone-to-metal bonding — and, after a healing period, supports a prosthetic restoration (crown, bridge, or overdenture). Since their introduction to clinical dentistry in the 1960s (Brånemark, Sweden), dental implants have transformed the management of tooth loss, offering a fixed alternative to removable prosthetics and a bone-preserving alternative to fixed bridges that require preparation of adjacent teeth.
Why It Matters
Implant knowledge is tested on board examinations through questions about: osseointegration biology; implant failure causes; bone quality classification; contraindications; peri-implant disease diagnosis and management; sinus augmentation principles; and implant timing after extraction. Clinically, implant surgery is now within the scope of the general dentist in many settings — understanding when to place, when to refer, and how to manage complications is an essential competency. Implant-related litigation is increasing as implant placement becomes more widespread and complications (nerve damage, peri-implantitis, aesthetic failures) generate patient complaints.
Osseointegration
At the molecular level, osseointegration begins the instant the implant contacts blood: plasma proteins (fibronectin, vitronectin, fibrinogen) adsorb to the implant surface within seconds, creating a provisional matrix. Platelets aggregate and degranulate, releasing growth factors (PDGF, TGF-β, BMP-2) that recruit osteogenic cells. Osteoprogenitor cells (derived from the periosteum and bone marrow) migrate to the implant surface and differentiate into osteoblasts, which deposit a collagen-proteoglycan matrix that subsequently mineralises as woven bone. Over weeks to months, woven bone is replaced by organised lamellar bone in direct contact with the implant surface (bone-implant contact, BIC). Histologically, osseointegrated implants show BIC values of 50–80% — not 100%, as some of the surface is always in contact with blood vessels, bone marrow, or soft connective tissue. The critical distinction: osseointegration is characterised by the complete absence of a fibrous tissue interface — if any fibrous tissue is present between implant and bone, the implant is not truly osseointegrated and will fail under load.
Treatment Planning
Patient Assessment
Comprehensive implant treatment planning requires: (1) medical history review — identify absolute contraindications (uncontrolled diabetes, active malignancy with bisphosphonates or radiation therapy, haematological disorders, psychological instability); relative contraindications (smoking >10 cigarettes/day reduces survival by ~10%; controlled diabetes; osteoporosis with bisphosphonate use — MRONJ risk); (2) oral health assessment — active periodontal disease, caries, and inadequate oral hygiene must be treated before implant placement; a patient who cannot maintain natural teeth will not maintain implants; (3) radiographic assessment — minimum: periapical X-ray; gold standard: CBCT for accurate bone height, width, and anatomical structure proximity; (4) occlusal assessment — bruxism, edge-to-edge bite, Class III malocclusion — all increase lateral force on implants; (5) aesthetic assessment — in the anterior region, lip line, smile line, gingival zenith, inter-tooth spacing, papilla height, and bone crest position all determine aesthetic predictability.
Implant Timing After Extraction
| ITI Type | Timing | Advantages | Disadvantages / Cautions |
|---|---|---|---|
| Type 1: Immediate | Day of extraction | Fewest appointments; maintains blood supply; patient preference | Requires intact socket walls; no acute infection; higher buccal plate resorption risk (aesthetic zone); requires gap grafting; needs experienced surgeon |
| Type 2: Early (soft tissue) | 4–8 weeks | Soft tissue cover improves flap management; can perform augmentation at placement; ideal for most augmentation cases | Increased total treatment time; some bone resorption has occurred |
| Type 3: Early (partial bone) | 12–16 weeks | Partial bone fill provides more support; less augmentation needed | Longer delay; moderate resorption has occurred |
| Type 4: Delayed/Late | >6 months | Complete healing; predictable bone anatomy; use if infection, staged augmentation, or systemic concerns | Maximum ridge resorption has occurred; may need more extensive augmentation |
Surgical Protocol
Standard implant surgical protocol: (1) Sterile surgical field — dental implant placement is a sterile procedure; sterile draping, sterile instruments, sterile irrigation saline; (2) Anaesthesia — local anaesthesia (infiltration or block as appropriate); consider conscious sedation for anxious patients; (3) Incision and flap reflection — crestal incision or flapless (using a tissue punch for guided/digital implant placement); full-thickness mucoperiosteal flap raised to expose the crest; (4) Osteotomy preparation (sequential drilling) — use the implant manufacturer’s drilled protocol; begin with a round bur to mark the site on the crest; advance sequentially with increasing-diameter twist drills; final drill = final implant diameter; irrigate copiously with sterile saline throughout drilling to prevent overheating of bone (bone necrosis occurs if temperature exceeds 47°C for >1 minute); (5) Implant insertion — insert implant using a torque-controlled handpiece; target insertion torque: typically 30–50 Ncm (higher = better primary stability; >70 Ncm = risk of bone microfracture from over-compression); resonance frequency analysis (RFA/ISQ) is an objective measure of implant stability (ISQ 60–80 = good primary stability; <55 = monitor closely); (6) Healing period — submerged (flap closed over the implant; second-stage surgery to place abutment after 6–12 weeks osseointegration) or non-submerged (transgingival healing abutment placed at surgery — allows one-stage procedure); (7) Prosthetic phase — after osseointegration, connect the abutment and fabricate the restoration; minimum loading time: 6–8 weeks for mandible (denser bone, faster osseointegration); 12–16 weeks for maxilla (less dense bone).
Bone Augmentation
Maxillary Sinus Floor Augmentation (Sinus Lift)
The lateral window sinus lift uses a window of bone cut in the lateral maxillary sinus wall (the Caldwell-Luc window) to access and elevate the Schneiderian membrane off the sinus floor. Bone graft material is packed into the space created between the elevated membrane and the sinus floor. Common graft materials: deproteinised bovine bone mineral (Bio-Oss — most studied, excellent long-term results); autogenous bone (gold standard biologically — but requires donor site); combination grafts. Implants placed simultaneously if ≥4–5mm residual bone for primary stability; otherwise, delayed placement after 6–9 months of graft healing. The osteotome (Summers) technique elevates the sinus floor through the implant osteotomy without a lateral window — appropriate when ≥5–6mm residual bone available; achieves 2–4mm elevation.
Guided Bone Regeneration (GBR)
GBR uses a barrier membrane to exclude fast-growing epithelial and connective tissue cells from a bone defect, allowing the slower-growing, osteogenic cells (from bone and periosteum) to fill the space. The membrane must be: (a) biocompatible; (b) occlusive (cells cannot penetrate); (c) space-maintaining (rigid enough or supported by bone graft to maintain the void); (d) integrated (with surrounding tissue). Membrane types: non-resorbable (expanded PTFE — e-PTFE — very effective; requires second surgical removal; titanium-reinforced for large defects; risk of exposure → bacterial contamination → GBR failure); resorbable (collagen membranes derived from bovine or porcine Type I/III collagen — resorb by enzymatic degradation in 4–26 weeks; no second surgery; currently the standard for routine defects). GBR graft materials: autograft (gold standard — osteogenic + osteoinductive + osteoconductive; donor site morbidity); allograft (freeze-dried bone allograft FDBA — osteoconductive; demineralised DFDBA — osteoinductive via exposed BMP); xenograft (Bio-Oss/deproteinised bovine — osteoconductive, slow resorption — excellent long-term volume maintenance); alloplast (synthetic — hydroxyapatite, beta-TCP — osteoconductive only).
Peri-implant Disease
| Feature | Peri-implant Mucositis | Peri-implantitis |
|---|---|---|
| Analogy | Gingivitis | Periodontitis |
| Inflammation | Yes (BOP, erythema, oedema) | Yes (BOP, suppuration, oedema) |
| Bone loss | No (beyond initial 1–2mm crestal remodelling) | Yes (progressive, ≥2–3mm from platform) |
| Reversibility | Reversible with treatment | Not fully reversible; may arrest with treatment |
| Prevalence | ~43–50% of implant patients | ~20–22% of implants; ~32% of patients at 5–10 yrs |
| Treatment | Mechanical debridement; oral hygiene instruction; CHX adjuncts; supportive care | Non-surgical + surgical (resective, regenerative, or explantation depending on defect morphology and extent) |
Implant Failure
Early failure (before loading/before osseointegration is complete): causes include surgical trauma (overheating, over-compression), infection (contaminated site, pre-existing pathology), systemic factors (uncontrolled diabetes, bisphosphonates), inadequate primary stability, premature loading. Late failure (after osseointegration, once loading begins): causes include peri-implantitis (most common cause of late failure), occlusal overload (bruxism, cantilever pontics, poorly designed prosthesis), inadequate bone quantity/quality, and technical complications (abutment screw fracture, implant fracture). Risk factors for implant failure: smoking (relative risk 2–3×); history of periodontitis; poor oral hygiene; uncontrolled diabetes; bruxism; irradiated bone (OSTEORADIONECROSIS risk); posterior maxilla (Type IV bone). Clinical diagnosis of failed implant: pain on percussion; mobility; progressive radiographic bone loss; inability to load. Management: if osseointegration has failed and implant is mobile, explant and allow healing; if peri-implantitis, treat accordingly; consider explantation for persistent infections or extensive bone loss.
Clinical Considerations
- Implant placement must be prosthetically driven — position is determined by the crown, not by the available bone: The most common cause of implant aesthetic and functional failure is incorrect implant positioning. The implant axis, depth, and mesiodistal/buccolingual position must be planned from the final restoration backward using a surgical guide (stent) fabricated from a diagnostic wax-up or digital plan. The implant platform should be: 2–3mm below the gingival margin in the anterior aesthetic zone (to allow an emergence profile that mimics natural tooth form); in the centre of the planned crown mesiodistally; and with the implant axis emerging through the cingulum of an anterior crown or the central fossa of a posterior crown. Failure to use a surgical guide leads to off-axis implants that generate excessive lateral forces and aesthetic compromises that cannot be corrected restoratively.
- The posterior superior alveolar artery runs in the lateral sinus wall and must be identified on CBCT before lateral window sinus lift: The posterior superior alveolar artery (PSAA) runs in the lateral wall of the maxillary sinus as it anastomoses with the infra-orbital artery. On CBCT, it appears as a low-density channel in the lateral sinus wall. If the lateral window bur inadvertently transects the PSAA, significant arterial haemorrhage follows — visibility is lost and the surgery may need to be abandoned. Pre-operative CBCT identification of the PSAA allows the surgeon to position the lateral window below the artery, avoiding it. An antrostomy above the artery is an alternative if bone height allows.
- Peri-implantitis prevention is more effective than treatment — the most important preventive measure is a strict maintenance protocol: Patients with implants must be enrolled in a supported implant therapy (SIT) programme with recall intervals determined by their peri-implant disease risk. At each maintenance appointment: peri-implant probing depths are recorded; BOP is assessed; radiographic bone level monitoring (standardised periapical radiographs) at baseline (at crown fit), 1 year, and annually if stable; professional debridement of biofilm from the peri-implant sulcus using non-metallic instruments (titanium curettes or PEEK instruments to avoid implant surface scratching). Patients who smoke should be strongly counselled about the twofold increased risk of peri-implantitis and implant failure.
- Retained sub-gingival cement is the most common iatrogenic cause of peri-implantitis and must be meticulously removed at the crown fit appointment: Cement-retained implant crowns carry an intrinsic risk of excess cement being expressed sub-gingivally at the time of crown cementation. Residual cement is not radio-opaque on standard radiographs (most dental cements are not) — it can be present for months to years before clinical peri-implantitis symptoms develop. Prevention: use screw-retained crowns wherever the implant axis permits (screw-retention has no cement — eliminates this risk); if cement-retained, use a minimal amount of cement, use a try-in protocol first, and probe all aspects of the peri-implant sulcus after cementation to detect and remove excess cement. Patients who develop early peri-implantitis should be questioned about their crown retention type — retained cement should be excluded as a cause before initiating peri-implantitis treatment.
- Diabetes mellitus significantly affects implant outcomes — only well-controlled diabetes (HbA1c <8%) is compatible with predictable osseointegration: Hyperglycaemia impairs neutrophil and macrophage function, reduces collagen synthesis, promotes advanced glycation end-product formation (which interferes with bone matrix), and causes microvascular disease (reducing blood supply to bone). Systematic reviews show that implant failure rates are significantly higher in patients with poorly controlled diabetes (HbA1c >10%) compared to non-diabetic patients and well-controlled diabetic patients. For patients with controlled diabetes (HbA1c <8%), implant survival rates are comparable to non-diabetic patients when combined with strict maintenance protocols. For patients with poorly controlled diabetes, implant placement should be deferred until glycaemic control is established.
Common Mistakes & Misconceptions
- Misconception: “Osseointegration means 100% bone-implant contact.”
Correction: Osseointegration describes the direct structural connection of living bone to the implant surface — but histological BIC (bone-implant contact) values are typically 50–80%, not 100%. The remaining interface is occupied by blood vessels, bone marrow, and connective tissue. Clinically, osseointegration is defined by the absence of any fibrous tissue at the bone-implant interface and the presence of clinically asymptomatic, rigid implant fixation during functional loading. An implant with 60% BIC that is clinically stable is successfully osseointegrated. - Misconception: “Immediate implant placement avoids bone loss after extraction.”
Correction: Immediate implant placement does not prevent buccal plate resorption, which occurs as a biologically programmed response to tooth loss regardless of implant placement timing. Studies consistently show that the buccal plate resorbs by approximately 1–2mm even with immediate implant placement. The implant-bone gap between the implant and the socket walls must be grafted (gap grafting) to manage this void. In the anterior aesthetic zone, immediate implants without careful gap grafting and provisionalization can result in significant buccal tissue recession and aesthetic failure. Socket preservation at the time of extraction remains the gold standard for maintaining bone volume when delayed implant timing is planned. - Misconception: “Implants should not be placed in patients on oral bisphosphonates for osteoporosis.”
Correction: The MRONJ risk from oral bisphosphonates for osteoporosis is low — particularly in patients taking them for less than 4 years without corticosteroid co-administration. Multiple systematic reviews have found that implant survival rates are not significantly different in patients on low-dose oral bisphosphonates compared to non-bisphosphonate controls. The contraindication and specialist referral threshold applies to patients on intravenous bisphosphonates (for cancer treatment, e.g., zolendronic acid, pamidronate) — where the MRONJ risk is substantially higher. A thorough medication history and risk discussion is required, but oral bisphosphonate use alone is not an absolute contraindication to implant placement. - Misconception: “A higher insertion torque always indicates better osseointegration.”
Correction: Higher insertion torque (up to ~50 Ncm) indicates better primary mechanical stability, which is desirable. However, insertion torques above 70 Ncm can cause excessive compressive stress on the bone at the implant thread level, leading to bone microfracture, osteocyte death, and paradoxically impaired osseointegration — the phenomenon of “insertion torque necrosis.” Very dense cortical bone (Type I) is most susceptible. If insertion torque is very high (approaching or exceeding 70 Ncm), reduce the depth of the osteotomy preparation or use a slightly larger final drill diameter to reduce the torque. - Misconception: “Peri-implantitis can be fully treated with non-surgical therapy alone in advanced cases.”
Correction: Non-surgical peri-implantitis therapy (mechanical debridement, adjunctive antiseptics/antibiotics) is effective for peri-implant mucositis and mild peri-implantitis, but evidence consistently shows that moderate to severe peri-implantitis (with significant bone loss) requires surgical access for effective debridement and management. Non-surgical therapy alone cannot adequately decontaminate a rough implant surface in a deep peri-implant pocket — the surface topography of SLA implants harbours biofilm in micro-pits that cannot be reached with curettes or irrigation from the sulcus. Surgical options (resective or regenerative) are required for progressive disease.
Related Topics
References & Sources
- Brånemark PI (1985). Introduction to osseointegration. In: Tissue-Integrated Prostheses. Quintessence. [Foundational text — original clinical osseointegration concept and long-term data]
- Zarb GA, Albrektsson T (1991). Osseointegration — a requiem for the periodontal ligament? International Journal of Periodontics and Restorative Dentistry, 11(2):88–91. [Zarb’s operational definition of osseointegration]
- Chen ST, Buser D (2009). Clinical and esthetic outcomes of implants placed in postextraction sites. International Journal of Oral and Maxillofacial Implants, 24(Suppl):186–217. [ITI consensus on implant timing classification]
- Berglundh T, Armitage G, Araujo MG, et al. (2018). Peri-implant diseases and conditions: Consensus report of workgroup 4 of the 2017 World Workshop. Journal of Periodontology, 89(Suppl 1):S313–S318. [2017 classification — peri-implant mucositis and peri-implantitis definitions]
- Tonetti MS, Cortellini P, Graziani F, et al. (2018). Immediate versus delayed implant placement after anterior single tooth extraction. Journal of Clinical Periodontology, 44(12):1341–1349.
- Summers RB (1994). A new concept in maxillary implant surgery: the osteotome technique. Compendium, 15(2):152–162. [Original Summers osteotome sinus elevation technique]
- Tatum H (1986). Maxillary and sinus implant reconstructions. Dental Clinics of North America, 30(2):207–229. [Lateral window sinus lift original description]
- Chrcanovic BR, Albrektsson T, Wennerberg A (2014). Smoking and dental implants: a systematic review and meta-analysis. Journal of Dentistry, 43(5):487–498. [Smoking doubles implant failure risk — meta-analysis of 107 studies]
Summary
Dental implant surgery is founded on osseointegration — the direct bone-to-titanium bond, first described by Brånemark and defined by Zarb. Bone quality (Lekholm-Zarb Types I–IV) is the strongest anatomical predictor of outcome, with Type IV bone in the posterior maxilla carrying the highest failure risk. Implant timing after extraction is classified by the ITI as Type 1 (immediate), 2 (early/soft tissue), 3 (early/partial bone), or 4 (delayed) — each with specific indications. The sinus lift (lateral window or transcrestal) augments the deficient posterior maxillary bone; Schneiderian membrane perforation is its most common intraoperative complication. Peri-implant mucositis (reversible soft tissue inflammation; ~43–50% prevalence) and peri-implantitis (progressive bone loss; ~20–22% of implants) parallel gingivitis and periodontitis and require a lifetime maintenance programme. History of periodontitis is the strongest systemic risk factor for peri-implantitis.
Key Takeaways
- Osseointegration: Brånemark (1952) discovery; Zarb (1991) definition. Direct bone-to-implant contact, no fibrous tissue. BIC = 50–80%. SLA surface = current standard. Primary stability = mechanical; secondary stability = biological (new bone).
- Bone quality: Type I (anterior mandible — densest, highest primary stability); Type IV (posterior maxilla — least dense, highest failure rate). CBCT mandatory for implant planning.
- Peri-implant disease: Mucositis (analogous to gingivitis; reversible; BOP, no bone loss). Peri-implantitis (analogous to periodontitis; bone loss; ~20–22% of implants). History of periodontitis = 3–4× increased risk. Retained cement = top iatrogenic cause.
- Sinus lift: Lateral window — Schneiderian membrane perforation = most common complication (<5mm repair and continue; >5mm terminate). Osteotome technique — when ≥5–6mm residual bone; 2–4mm elevation achievable.
- Key contraindications: Active malignancy + IV bisphosphonates; uncontrolled diabetes (HbA1c >9%); irradiated jaw bone; active infection at site. Oral bisphosphonates for osteoporosis are NOT an absolute contraindication.
About the Author
